Safety of cerebrolysin for neurorecovery after acute ischemic stroke: A systematic review and meta-analysis of twelve randomized-controlled trials

Stefan Strilciuc*, László Vécsei, Dana Boering, Aleš Pražnikar, Oliver Kaut, Peter Riederer, Leontino Battistin

*Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

129 Downloads (Pure)

Abstract

We performed a systematic search and meta-analysis of available literature to determine the safety profile of Cerebrolysin in acute ischemic stroke, filling existing safety information gaps and inconsistent results. We searched EMBASE, PubMed, and Cochrane Databases of Systematic Reviews and Clinical Trials up to the end of February 2021. Data collection and analysis were conducted using methods described in the Cochrane Handbook for Systematic Reviews of Interventions. All safety outcomes were analyzed based on risk ratios (RR) and their 95% confidence intervals. The meta-analysis pooled 2202 patients from twelve randomized clinical trials, registering non-statistically significant (p > 0.05) differences between Cerebrolysin and placebo throughout main and subgroup analyses. The lowest rate of Serious Adverse Events (SAE), as compared to placebo, was observed for the highest dose of Cerebrolysin (50 mL), highlighting a moderate reduction (RR = 0.6). We observed a tendency of superiority of Cerebrolysin regarding SAE in high dose treatment courses for moderate-severe ischemic stroke, suggesting some effect of the agent against adverse events. This comprehensive safety meta-analysis confirms the safety profile for patients treated with Cerebrolysin after acute ischemic stroke, as compared to placebo.

OriginalsprogEngelsk
Artikelnummer1297
TidsskriftPharmaceuticals
Vol/bind14
Udgave nummer12
Antal sider11
ISSN1424-8247
DOI
StatusUdgivet - dec. 2021

Bibliografisk note

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Fingeraftryk

Dyk ned i forskningsemnerne om 'Safety of cerebrolysin for neurorecovery after acute ischemic stroke: A systematic review and meta-analysis of twelve randomized-controlled trials'. Sammen danner de et unikt fingeraftryk.

Citationsformater